Terns Pharmaceuticals, Inc. · NASDAQ:TERN

Commodore Capital LP reported a 6.50% stake in Terns Pharmaceuticals, Inc. (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 14, 2025

Commodore Capital LP reported a 6.50% stake in Terns Pharmaceuticals, Inc., 5,700,000 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).

Stake
6.50%
Shares
5,700,000
Intent
Passive
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
Commodore Capital LP6.50%5,700,000
Commodore Capital Master LP6.50%5,700,000
Robert Egen Atkinson6.50%5,700,000
Michael Kramarz6.50%5,700,000

Source

View original at SEC

Related